Original article
A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study
Jeffrey V. Lazarusa,b,
, William Alazawic, Ron Basuroyd, Laurent Casterae, Dmitry Estulinf, Yiannoula Koullag, Preethy Prasadd, Manuel Romero-Gomezh, Hirokazu Takahashii,j, Vincent Wai-Sun Wongk, Jörn M. Schattenbergl
Corresponding author
a CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, United States
b Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain
c Barts Liver Centre, Blizard Institute, Queen Mary University London, London, United Kingdom
d Novo Nordisk, Copenhagen, Denmark (affiliated at the time of submission)
e Department of Hepatology, Hospital Beaujon AP-HP, University of Paris, Clichy, France
f Novo Nordisk, Zurich, Switzerland
g European Liver Patients’ Association, Brussels, Belgium
h Digestive Diseases Department and Ciberehd, Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (HUVR/CSIC/US), University of Seville, Seville, Spain
i Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan
j Liver Center, Saga University Hospital, Saga, Japan
k The Chinese University of Hong Kong, Hong Kong
l Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany
Ver más
